Sjögren's syndrome: an autoimmune disorder with otolaryngological involvement
- PMID: 16450767
- PMCID: PMC2639870
Sjögren's syndrome: an autoimmune disorder with otolaryngological involvement
Abstract
Sjorgen's syndrome (SS) is an autoimmune exocrinopathy characterized by lymphocyte infiltration of salivary and lacrimal glands that leads to progressive xerostomia and xerophtalmia. One-third of patients suffer of systemic manifestations including arthritis, fever, fatigue and mucosal dryness whereas those with major salivary involvement show an increased risk to develop low-grade non-Hpdgkin lymphomas. In addition, a minority of patients show symptoms related to progressive hearing loss whose pathogenesis remains undefined. Both deposition of autoantibodies to antigens of the inner-ear structures and infiltration by autoreactive T-cells have been implicated in its pathogenesis. In this context, high levels of autoantibodies to both cardiolipin and M3 muscarinic receprtors as well as to ciliar epitopes of the cochlear cells have been recently described. Here we review recent advances on the pathodgenesis of SS with a particular focus to otolaryngological manifestations.
La sindrome di Sjörgen (SS) è una esocrinopatia autoimmune prevalentemente caratterizzata da progressiva xerostomia e xeroftalmia. La malattia si manifesta in circa un terzo dei pazienti con sintomi sistemici tra cui artriti, febbre, astenia e secchezza delle mucose. Tuttavia, i pazienti con prevalente interessamento delle ghiandole salivari maggiori presentano aumentato rischio di sviluppo di malattie di tipo linfoproliferativo, tra cui il linfoma non-Hodgkin. In una minoranza di pazienti è presente coinvolgimento di tipo neurosensoriale e vasculitico delle strutture cocleari con progressiva riduzione delle capacità uditive. Dal punto di vista patogentico elevati livelli di anticorpi anticardiolipina, anti-recettori muscarinici ed anti-epitopi ciliari delle cellule cocleari potrebbero svolgere un ruolo significativo nella perdita della funzione neurosensoriale uditiva. In questa rassegna vengono rivisitati alcuni tra i meccanismi immunopatologici principali responsabili della cmparsa di manifestazioni di interesse otorinolaringologico nei pazienti con SS.
Figures

Similar articles
-
The frequency of sicca symptoms and Sjögren's syndrome in patients with systemic sclerosis.Int J Rheum Dis. 2013 Feb;16(1):88-92. doi: 10.1111/j.1756-185X.2012.01810.x. Epub 2012 Aug 31. Int J Rheum Dis. 2013. PMID: 23441777
-
Sjögren's syndrome in systemic lupus erythematosus.J Rheumatol. 1990 Feb;17(2):201-4. J Rheumatol. 1990. PMID: 2319519
-
The geoepidemiology of Sjögren's syndrome.Autoimmun Rev. 2010 Mar;9(5):A305-10. doi: 10.1016/j.autrev.2009.11.004. Epub 2009 Nov 10. Autoimmun Rev. 2010. PMID: 19903539 Review.
-
Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome.J Autoimmun. 2010 Jun;34(4):400-7. doi: 10.1016/j.jaut.2009.10.004. Epub 2009 Nov 3. J Autoimmun. 2010. PMID: 19889514
-
[Sjögren's syndrome in the elderly].Ann Med Interne (Paris). 2002 Oct;153(6):378-82. Ann Med Interne (Paris). 2002. PMID: 12486386 Review. French.
Cited by
-
Successful treatment of sensorineural hearing loss in Sjögren's syndrome with corticosteroid.Korean J Intern Med. 2016 May;31(3):612-5. doi: 10.3904/kjim.2014.303. Epub 2016 Apr 8. Korean J Intern Med. 2016. PMID: 27055663 Free PMC article. No abstract available.
-
Brainstem auditory evoked potentials in patients with primary Sjögren's syndrome without central nervous system involvement.Clin Rheumatol. 2021 Mar;40(3):991-997. doi: 10.1007/s10067-020-05344-5. Epub 2020 Aug 18. Clin Rheumatol. 2021. PMID: 32809145 Free PMC article.
-
CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.Pathogens. 2022 Jul 25;11(8):831. doi: 10.3390/pathogens11080831. Pathogens. 2022. PMID: 35894054 Free PMC article. Review.
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.Clin Transl Allergy. 2020 Jan 3;10:1. doi: 10.1186/s13601-019-0303-6. eCollection 2020. Clin Transl Allergy. 2020. PMID: 31908763 Free PMC article. Review.
-
Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjögren's syndrome murine model.PLoS One. 2022 May 5;17(5):e0266137. doi: 10.1371/journal.pone.0266137. eCollection 2022. PLoS One. 2022. PMID: 35511824 Free PMC article.
References
-
- Moysan JF, Jouquan J, Gerard C, Pennec Y, Le Goff P, Youinou P. Is the target of anti-cardiolipin antibodies the same in Gougerot-Sjögren syndrome and lupus erythematosus disseminatus? Rev Med Intern 1987;8:163-8. - PubMed
-
- Novoselov VI, Peshenko IV, Evdokimov VJ, Nikolaev JV, Matveeva EA, Fesenko EE. Water-soluble GTP-binding protein from rat olfactory epithelium. FEBS Lett 1994;353:286-8. - PubMed
-
- Sone M, Nariuchi H, Saito K, Yanagita N. A substrain of NZB mouse as an animal model of autoimmune inner ear disease. Hear Res 1995;83:26-36. - PubMed
-
- Trune DR. Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss. Otolaryngol Head Neck Surg 1997;117:504-8. - PubMed
-
- Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjögren’s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren’s Syndrome. Arthritis Rheum 1999;42:1765-72. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical